William Blair analyst Brandon Vazquez has maintained their bullish stance on ISRG stock, giving a Buy rating yesterday.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Brandon Vazquez has given his Buy rating due to a combination of factors that highlight Intuitive Surgical’s strong operating momentum and durable growth profile. He points to revenue and earnings significantly exceeding consensus expectations, driven primarily by robust international system placements, favorable pricing, and better-than-anticipated margins supported by operating leverage.
At the same time, he notes that rising utilization of the newer DV5 platform, rapid expansion of emergent procedures, and accelerating adoption outside the U.S. are creating structural tailwinds that more than offset regional softness and mixed procedure trends. Although valuation is elevated and viewed as the primary risk, he believes the company’s best‑in‑class financial profile and long runway for global adoption justify maintaining a Buy recommendation.
In another report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $620.00 price target.